首页> 外文期刊>Clinical hemorheology and microcirculation >Timolol effects on erythrocyte deformability and nitric oxide metabolism
【24h】

Timolol effects on erythrocyte deformability and nitric oxide metabolism

机译:蒂莫尔对红细胞变形性和一氧化氮代谢的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Timolol maleate is a compound used in treatment for reducing increased intra-ocular pressure by limiting aqueous humor production. Decreased erythrocyte deformability (ED), increased activity of erythrocyte acetylcholinesterase (AChE), increased values of nitrosoglutathione (GSNO) and nitic oxide (NO) and decreased plasma levels of NO metabolites, were described in primary open angle glaucoma patients. In healthy human red blood cells (RBCs), timolol is an inhibitor of AChE and induces NO efflux and GSNO efflux from that blood component in lower concentration than those obtained in presence of the natural AChE substrate, acetylcholine (ACh). The signal transduction pathway in RBCs described for NO in dependence of AChE-ACh active complex involves Gi protein, protein tyrosine kinase (PTK like Syk and p53/56Lyn), protein tyrosine phosphatase (PTP) and adenylyl cyclase (AC). The aim of this in vitro study was to verify the effect of timolol maleate in ED, NO efflux and NO derivatives molecules (NOx) like nitrite (NO2~), nitrate (NO3~, peroxynitrite (~ONOO) and GSNO under the presence of PTK, PTP, AC and guanylyl cyclase (GC) enzyme proteins inhibitors. Blood samples from healthy donors were each one divided and were performed aliquots in absence (control aliquots) and presence of timolol or timolol plus each inhibitor and Gi protein uncoupling. No significant differences in erythrocyte NO efflux, GSNO, peroxynitrite, nitrite and nitrate concentrations in response to timolol when compared with the untreated blood samples aliquots were obtained. It was observed an increase in erythrocyte deformability at high shear stresses induced by the simultaneous presence of timolol and band 3 protein dephosphorylation by PTK syk inhibitor. No significant differences where verified in peroxynitrite levels in the blood aliquots in presence of timolol plus each enzyme inhibitor and Gi protein uncoupling in relation to the control aliquots. No variation of GSNO concentration occurs under the presence of timolol and AMGT (PTK lyn inhibitor) besides the significant higher values observed with each one of the other inhibitors. Nitrate concentration increases significantly in all aliquots with timolol plus each one of the inhibitors. The same was observe with nitrite levels with exception of the aliquots with timolol plus AMGT or timolol plus Gi protein uncoupling showing no significant values in relation to the control aliquots. Besides the changes in NO derivative molecules and NO efflux from RBCs obtained in this study with blood samples of healthy donors under the effect of timolol plus each inhibitor of the proteins participants in NO signal transduction mechanism, further analogue studies must be promoted with blood samples of patients with glaucoma or any other inflammatory vascular disease.
机译:Motolol Maleate是一种用于治疗的化合物,用于通过限制液压性生产来降低眼压内压增加。降低红细胞变形性(ED),在原发性开口角膜青光眼患者中描述了红细胞乙酰乙酰胆碱酯酶(ACHE)的增加的红细胞乙酰乙酰胆碱酯酶(ACHE)的活性,亚硝孢子素(GSNO)和荷坦氧化物(NO)的增加和降低的等离子体水平,在一次性开口荧光眼患者中描述。在健康的人红细胞(RBCS)中,蒂洛尔是疼痛的抑制剂,并诱导血液成分的血液组分低于在天然疼痛基材(ACH)的存在下获得的血液组分的流出和GSNO流出。用于ache-ACH活性复合物的NO不依赖的RBC中的信号转导通路涉及GI蛋白,蛋白酪氨酸激酶(PTK等SYK和P53 / 56LYN),蛋白酪氨酸磷酸酶(PTP)和腺苷酸环酶(AC)。这种体外研究的目的是验证蒂洛尔马来酸在Ed,没有衍生物和没有衍生物分子(NOx)等亚硝酸盐(NO 2〜),硝酸盐(NO 3〜,Peroxynitrite(〜ONOO)和GSNO在存在下的衍生物分子(NOx)的影响PTK,PTP,AC和瓜梵烯蛋白酶(GC)酶蛋白抑制剂。来自健康供体的血液样本每一个分开,在不存在(对照等分试样)和蒂洛尔或蒂洛尔的存在加上每种抑制剂和GI蛋白质不耦合的等分试样。没有显着的与未处理的血液样品相比,红细胞NOREFLUX,GSNO,过氧化物,亚硝酸盐和硝酸盐浓度的差异是较响应的。它被观察到通过同时存在蒂洛尔和带的高剪切应力下的红细胞变形性增加PTK Syk抑制剂3蛋白脱磷。没有显着差异,在蒂莫尔加上每种酶的血液等分试样中的过氧纯度水平验证IBitor和GI蛋白与对照等分试样有关的解耦。除了用每种其他抑制剂中观察到的显着较高值之外,没有在蒂洛尔和AMGT(PTK Lyn抑制剂)的存在下发生GSNO浓度的变化。硝酸盐浓度在所有等分试样的硝酸盐加上每种抑制剂中的等分试样增加。同样观察到亚硝酸盐水平,用蒂洛尔加上的等分试样与氏炎氏炎氏炎或蒂洛尔加上Gi蛋白质非象耦合,显示与对照等分试样无明显的值。除了在本研究中获得的RBC没有衍生物分子的变化以及HITOLOL对蛋白质参与者的每种抑制剂没有信号转导机制的每种抑制剂的血液样本,必须用血液样本促进进一步的类似物研究青光眼或任何其他炎症血管疾病的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号